Entering text into the input field will update the search result below

Achillion set for gap up at the open

  • Achillion Pharmaceuticals (NASDAQ:ACHN) is up 6% premarket on high volume in response to the prevailing opinion that yesterday's 24% plunge on 4x normal volume was overdone. The AbbVie/Express Scripts deal stoked the biotech/pharma sell-off.
  • Previously: Money flowing out of biotech today (Dec. 23)

Recommended For You

About AAQL Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
AAQL--
Antiaging Quantum Living Inc.